Furthermore, G-CSF administration has shown efficacy in patients experiencing non-chemotherapy idiosyncratic drug-induced neutropenia, commonly associated with rheumatic or psychiatric drugs or even disease-induced neutropenia. The gene discussed is CSF3; the disease is Decreased total neutrophil count.